SciVision Biotech Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 127.27 million compared to TWD 120.96 million a year ago. Net income was TWD 20.09 million compared to TWD 34 million a year ago. Basic earnings per share from continuing operations was TWD 0.3 compared to TWD 0.51 a year ago. Diluted earnings per share from continuing operations was TWD 0.3 compared to TWD 0.5 a year ago. For the nine months, sales was TWD 365.3 million compared to TWD 334.95 million a year ago. Net income was TWD 76.35 million compared to TWD 92.71 million a year ago. Basic earnings per share from continuing operations was TWD 1.15 compared to TWD 1.4 a year ago. Diluted earnings per share from continuing operations was TWD 1.13 compared to TWD 1.37 a year ago.